08037.HK
China Biotech Services Holdings Limited
HKSE · Healthcare · Medical - Diagnostics & Research · HK
HKD 0.63
+3.28%Margins
Gross margin
12.8%
EBITDA margin
-66.6%
EBIT margin
-110.1%
Net margin
-37.8%
FCF margin
-215.3%
-16.0%
Return on equity
-4.2%
Return on assets
-14.8%
Return on invested capital
0.12x
Asset turnover
-HKD 54.5M
Cash from operations
HKD 0.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026